- Glupczynski Y, Bogaerts P, Deplano A, Berhin C, Huang TD, Van Eldere J,Rodriguez-Villalobos H. Detection and characterization of class A extended-spectrum-beta-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals. J Antimicrob Chemother. 2010 May;65(5):866-71. doi: 10.1093/jac/dkq048. Epub 2010 Mar 3.PubMed PMID: 20200037
|
- Poirel L, Docquier JD, De Luca F, Verlinde A, Ide L, Rossolini GM, Nordmann P.BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2010 Jan;54(1):533-5. doi: 10.1128/AAC.00859-09. Epub 2009 Nov 2.PubMed PMID: 19884378
|
- Juan C, Zamorano L, Pérez JL, Ge Y, Oliver A; Spanish Group for the Study of Pseudomonas; Spanish Network for Research in Infectious Diseases. Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains. Antimicrob Agents Chemother. 2010 Feb;54(2):846-51. doi: 10.1128/AAC.00834-09. Epub 2009 Nov 23.PubMed PMID: 19933793
|
- Poirel L, Brinas L, Verlinde A, Ide L, Nordmann P. BEL-1, a novel clavulanic acid-inhibited extended-spectrum beta-lactamase, and the class 1 integron In 120 Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2005 Sep;49(9):3743-8.PubMed PMID: 16127048
|